Diagnostic methods of multiple organ amyloidosis

作者: Francine Gervais

DOI:

关键词: Diagnostic methodsAmyloidosisAlleleAntibodyHepatocyte growth factorImmunoglobulin light chainSerum amyloid ASerum albuminPathologyBiology

摘要: Described are methods of assessing whether a subject has or is at risk having multiple organ amyloidosis (MOA) The method includes detecting diagnostically predictive collection biomarkers amyloidosis, wherein the detection indicates Also described monitoring treatment subjects with and evaluating therapeutic compounds Representative for use in may be selected from variant serum amyloid A (SAA) allele, elevated SAA level, C-reactive protein (CRP) depressed glycosammoglycan (GAG) mterleukm -18 (IL-18) macrophage-colony stimulating factor (M-CSF) hepatocyte growth (HGF) presence an antibody against citrullmated vimentm (Sa), monoclonal immunoglobulin light chain, increased albumin, creatinine clearance

参考文章(10)
Esra Baskin, Umit Saatçi, Gönenç Ciliv, Aysin Bakkaloglu, Nesrin Besbas, Rezan Topaloglu, Seza Ozen, Urinary glycosaminoglycans in the course of familial Mediterranean fever. European Journal of Pediatrics. ,vol. 162, pp. 305- 308 ,(2003) , 10.1007/S00431-003-1173-3
Masahiko SHIKANO, Hiroko KUSHIMOTO, Hiroshi HASEGAWA, Makoto TOMITA, Midori HASEGAWA, Kazutaka MURAKAMI, Shirou KAWASHIMA, Usefulness of Serum Hepatocyte Growth Factor for the Diagnosis of Amyloidosis. Internal Medicine. ,vol. 39, pp. 715- 719 ,(2000) , 10.2169/INTERNALMEDICINE.39.715
Tadashi Nakamura, Yuji Yamamura, Kunihiko Tomoda, Michishi Tsukano, Masahiro Shono, Satoshi Baba, Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis Clinical Rheumatology. ,vol. 22, pp. 371- 375 ,(2003) , 10.1007/S10067-003-0763-9
R. Rysavá, M. Merta, V. Tesar, M. Jirsa, T. Zima, CAN SERUM AMYLOID A OR MACROPHAGE COLONY STIMULATING FACTOR SERVE AS MARKER OF AMYLOID FORMATION PROCESS Iubmb Life. ,vol. 47, pp. 845- 850 ,(1999) , 10.1080/15216549900201933
Fumiko Tanaka, Kiyoshi Migita, Yojiro Kawabe, Takahiko Aoyagi, Hiroaki Ida, Atsushi Kawakami, Katsumi Eguchi, Interleukin-18 induces serum amyloid A (SAA) protein production from rheumatoid synovial fibroblasts Life Sciences. ,vol. 74, pp. 1671- 1679 ,(2004) , 10.1016/J.LFS.2003.08.025
M. S. Pepe, Combining diagnostic test results to increase accuracy Biostatistics. ,vol. 1, pp. 123- 140 ,(2000) , 10.1093/BIOSTATISTICS/1.2.123
Hani S El-Gabalawy, John A Wilkins, Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis. Arthritis Research & Therapy. ,vol. 6, pp. 86- 89 ,(2004) , 10.1186/AR1171
J. Tencer, O. Torffvit, A. Grubb, S. Bjornsson, H. Thysell, B. Rippe, Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis. Nephrology Dialysis Transplantation. ,vol. 12, pp. 1161- 1166 ,(1997) , 10.1093/NDT/12.6.1161
M. Moriguchi, C. Terai, Y. Koseki, M. Uesato, A. Nakajima, S. Inada, M. Nishinarita, S. Uchida, A. Nakajima, S.Y. Kim, C.-L. Chen, N. Kamatani, Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis Human Genetics. ,vol. 105, pp. 360- 366 ,(1999) , 10.1007/S004399900150
Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E. Witzig, John A. Lust, Martha Q. Lacy, Terry M. Therneau, A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine New England Journal of Medicine. ,vol. 336, pp. 1202- 1207 ,(1997) , 10.1056/NEJM199704243361702